In consultation: Guidance and quality standards

Skip to filtersSkip to results

Skip to results

Keyword or reference number

Consultation end date

Type

Showing 1 to 14 of 14

TitleConsultationTypeConsultation end date
Amivantamab with carboplatin and pemetrexed for untreated EGFR exon 20 insertion mutation-positive advanced non-small-cell lung cancer [ID5110]Draft guidanceTechnology appraisal guidance
Nemolizumab for treating moderate to severe atopic dermatitis in people 12 years and over ID6221Draft guidanceTechnology appraisal guidance
Durvalumab with platinum-based chemotherapy, then with or without olaparib, for treating newly diagnosed advanced or recurrent endometrial cancer ID6317Draft guidanceTechnology appraisal guidance
Overweight and obesity managementQuality standard consultationQuality standard
Intrapartum Care - maternal hyponatremiaDraft guidance consultationNICE guideline
Pembrolizumab with carboplatin and paclitaxel for untreated advanced or recurrent endometrial cancer [ID6381]Draft guidanceTechnology appraisal guidance
Abortion CareDraft guidance consultationNICE guideline
Natalizumab (originator and biosimilar) for treating highly active relapsing–remitting multiple sclerosis after disease-modifying therapy [ID6369]Draft guidanceTechnology appraisal guidance
Lecanemab for treating mild cognitive impairment or mild dementia caused by Alzheimer's disease [ID4043]Draft guidanceTechnology appraisal guidance
Donanemab for treating mild cognitive impairment or mild dementia caused by Alzheimer's disease [ID6222]Draft guidanceTechnology appraisal guidance
Cemiplimab with platinum-based chemotherapy for untreated advanced non-small-cell lung cancer [ID3949]Draft guidanceTechnology appraisal guidance
Idebenone for treating visual impairment in Leber's hereditary optic neuropathy in people 12 years and over [ID547]Draft guidanceTechnology appraisal guidance
Cardiovascular risk assessment and lipid modificationQuality standard consultationQuality standard
Sparsentan for treating primary IgA nephropathy [ID6308]Draft guidanceTechnology appraisal guidance

Results per page

  1. 10
  2. 25
  3. 50
  4. All